Today, we celebrate four years since Phlow announced that it would act boldly and swiftly to protect America’s medicine cabinet. Since then, our team has embarked on an unwavering mission to ensure a future where every American has access to the essential medicines necessary to sustain life and conquer disease. Thanks to the support of the United States Government through the U.S. Department of Health and Human Services (HHS) Administration for Strategic Preparedness and Response (ASPR), Phlow is helping to create domestic supply chain resiliency and reliability for our country’s most vital medicines. Although we have achieved a great deal in just four years, there is still much work to be done to prevent drug shortages and secure America’s pharmaceutical sovereignty. As a modern medicine manufacturer, we are committed to pushing beyond the boundaries of the status quo. Watch the video to learn more: https://lnkd.in/eQTzZqNQ #SupplyChainResiliency #EssentialMedicines #DrugShortages #BCorp HHS Administration for Strategic Preparedness and Response
Phlow’s Post
More Relevant Posts
-
𝗘𝗺𝗯𝗮𝗿𝗸𝗶𝗻𝗴 𝗼𝗻 𝗮 𝗷𝗼𝘂𝗿𝗻𝗲𝘆 𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝘁𝗵𝗲 𝘀𝘁𝗮𝗴𝗲𝘀 𝗼𝗳 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹𝘀 From safety evaluations to real-world effectiveness. Phase by phase, we unravel the mysteries of new treatments, addressing crucial questions about ✅ Safety ✅Efficacy ✅Long-term impacts From the cautious steps of Phase 1 to the comprehensive assessments of Phase 3, each stage brings us closer to understanding and improving healthcare. Each stage plays a vital role in shaping the future of medicine. Join us as we navigate through the complexities, towards better outcomes for all. #clinicalresearch #pharma #healthcare #medicalscience
-
Connected drug delivery devices and digital health solutions at a new maturity level including impressive operational examples.
Conversations sparked by Chelsea Williams, MPH’s poster at the PDA - Parenteral Drug Association Medical Devices and Connected Health Conference were truly inspiring, and we were excited to further connect with other industry professionals. We’d like to say thank you 🙏 to everyone who contributed to these enlightening exchanges. Follow our page to get the latest updates on SHL Medical’s innovative breakthroughs and upcoming commercial activities! #ThankYou #DrugDelivery #ConnectedHealth
-
-
Manufacturers of generic and biosimilar medicine play a critical role in widening access to essential medicine globally. Given only 10% of the drugs on the World Health Organization’s list of essential medicines are on-patent, the size of the opportunity and impact is vast https://ow.ly/e5Ie50Tqlmi
-
-
📢 SCHEER Consultation Alert! 📢 ◾ The European Commission and its Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) have launched a crucial public consultation on the preliminary update of guidelines concerning the presence of phthalates in certain medical devices. ◾ Phthalates, known for their carcinogenic, mutagenic, toxic to reproduction (CMR), or endocrine-disrupting (ED) properties, are under scrutiny. ◾ Manufacturers, regulatory bodies, and stakeholders, your input is vital! 📅 Deadline: April 28, 2024 🔗 Link: https://lnkd.in/eZZwXHbY ◾ Let's ensure the safety and efficacy of medical devices for all. Share your insights now! #PublicHealth #SCHEERConsultation #MedicalDevices #MDR #IVDR #MDSS #ECREP #SCHEER #EU #Europeanmarket
-
According to The State of Drug Diversion 2023 Report, there are still many opportunities for drug diversion awareness within our health systems, as many facilities are still highly dependent on internal audits, anonymous tips and Automated Dispensing Cabinet (ADC) reports. Read more in this Pharmacy Times article by our own Stacey McCoy, PharmD, MS, BCPS. https://ow.ly/lZyO50QnxNY
-
-
Founder & Chairman, Real Chemistry; Executive Advisor, New Mountain Capital; Entrepreneur, Investor, Board Member, Advisor
Excited to announce Real Chemistry's first product from our Transformative Healthcare Markets team, focusing on the game-changing impact of GLP-1s in #healthcare, especially on #obesity and beyond. This class of drugs is reshaping patient-HCP relationships in revolutionary ways and our debut report uncovers unexpected drivers behind this shift. Discover how GLP-1s are shaping the future: https://lnkd.in/g4mPA5e6
-
-
Any visit with a Field Medical representative is better than none. Our data, based on over 45,000 interactions, shows that just one annual visit significantly boosts your perception as a valued medical partner. This first visit lays the foundation for future interactions, fostering two-way dialogue, maintaining communication channels, and exchanging updated industry insights. Learn more about balancing the quality and frequency of medical interactions. 👉 Read our paper here: https://loom.ly/idPMf-c 👍 Follow Trilations Healthcare Strategies for more medical insights: https://loom.ly/idPMf-c #trilationsmedical #pharma #medicalaffairs #healthcare #fieldmedical #medicalengagement
-
Debridement is a crucial part of wound healing, but the lack of a consistent global standard of care poses significant challenges. Addressing this issue requires the development of easily applicable products that nurses can use, not only in hospitals, but also in clinics or patients' homes. In an interview with Radcliffe Vascular, our Director of Regulatory Affairs, David Fairlamb, discusses the Phase 2a results of our CLEANVLU study investigating Aurase Wound Gel, our first investigational product. Aurase Wound Gel is a hydrogel containing an enzyme cloned from medical maggots which aims to be the first treatment that targets all elements of wound bed preparation—one that is cost-effective, fast, efficacious, pain-free, and easy-to-use. Watch the full video here: https://shorturl.at/isuFT #ChronicWounds #ClinicalTrial #WoundCare
-
-
Take an in-depth look at Semaglutide side effects in Part 6, tailored for medical providers. Enhance your knowledge and visit [https://lnkd.in/gsn-ADKe] for comprehensive training. #InDepthSideEffects #Semaglutide #6
-
CIO Advisory Partner | CTO | Technology Strategy | Corporate Strategy Innovation Selection Committee Member |AI & ML | Senior/Principal Quantum Computing Team Leader
But, beyond the workout routines and testosterone parties, groundbreaking advancements are occurring in the health care industry every day. Did you know that in 2023, the FDA approved 55 new drugs? This is the second-highest number in the last 30 years. The healthcare industry is constantly evolving and improving to provide better care for patients. Let's keep our eyes on the future and continue to support the advancements that will make a difference in people's lives. #healthcare #FDAapproved #medicaladvancements
Sr. Director Business Development at Escientia Life Sciences/Flextronics
4moNo better historical event than COVID-19 to bear all lights about America’s (and all other countries) exposure to drug shortages. In almost every case - the essential medicines we needed were international flights away in countries with closed borders. Being prepared takes on new meaning when our families, friends, and neighbors are impacted and in need. The development and deployment necessary to manufacture essential medicines was, is, and will be paramount to America’s primary health systems for many years to come. HHS, ASPR, Phlow and many others have been steadfast in achieving this goal. Active Pharmacaeutical Ingredients (APIs) and Drug Master Files (DMFs) and the associated regulatory approvals - it all sounds so simple… Congratulations to the Phlow team, their partners and stakeholders for milestones met to date, and having the vision and commitment to the future of human health.